Integra LifeSciences has identified issues with certain wound and burn products that have resulted in serious injuries, the Food and Drug Administration said.

Monday, Integra LifeSciences Holdings Corporation (NASDAQ:IART) reported first-quarter revenues of $368.9 million, down 3.1% Y/Y on a reported basis and 2.5% on an organic basis, beating the consensus ...

PRINCETON, N.J., Aug. 21, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holding Company (NASDAQ: IART), a leading global medical technology company, today issued its latest Environmental, Social and ...

Jan De Witte to retire as CEO by the end of 2024Stuart Essig appointed executive chairman of the Board “We are grateful to Jan for his leadership and commitment to Integra and the role he has played ...

On Monday, Integra LifeSciences Holdings Corporation (NASDAQ:IART) reported third-quarter adjusted EPS of $0.41, down from $0.76 a year ago, beating the consensus of $0.39. The company reported sales ...

PRINCETON, N.J., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (IART) (Nasdaq:IART) today announced the appointment of Dr. Raymond Turner as its new corporate vice ...

PRINCETON, N.J., April 01, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced it has successfully completed ...

Integra LifeSciences released the Integra Freedom Wrist Arthroplasty System in the United States. The system, which is used in the treatment of wrist arthritis, has been successfully implanted in 21 ...

Integra LifeSciences Holdings Corp. is seeking to establish itself in the ear, nose and throat category with its acquisition of Acclarent Inc. The Princeton-based medical technology company announced ...

NJBIZ, New Jersey’s leading business journal, provides 24/7 business news coverage and events honoring top business professionals.